Perceive Pharma Inc.

Perceive Bio develops therapeutic treatments for retinal degeneration diseases, including dry age-related macular degeneration and neuroprotection, using multiple therapeutic modalities based on proprietary protective biology research. The company's pipeline is based on exclusive access to decades of academic research aimed at preventing major causes of irreversible blindness.